Organ at Risk Dose Constraints in SABR: A Systematic Review of Active Clinical Trials

SABR波动模型 医学 临床试验 四分位间距 医学物理学 核医学 放射科 外科 内科学 随机波动 波动性(金融) 金融经济学 经济
作者
Serenna G. Gerhard,David A. Palma,Andrew Arifin,Alexander V. Louie,Li G,Faiez Al-Shafa,Patrick Cheung,George Rodrigues,Carol W. Bassim,Mark T. Corkum
出处
期刊:Practical radiation oncology [Elsevier BV]
卷期号:11 (4): e355-e365 被引量:60
标识
DOI:10.1016/j.prro.2021.03.005
摘要

Organ at risk (OAR) dose constraints are a critical aspect of SABR treatment planning. There is limited evidence supporting preferred dose constraints for many OARs. We sought to evaluate OAR dose constraints used in ongoing clinical trials of SABR for oligometastatic disease.Clinicaltrials.gov was searched from inception to February 2020 to capture actively accruing clinical trials using SABR in oligometastatic disease. Dose constraints were obtained by contacting principal investigators and abstracted by 2 authors. Variability of constraints was assessed by comparing the width of the interquartile range and difference between the maximum and minimum dose to a volume.Fifty-three of 85 eligible clinical trials contributed OAR constraints used in analysis. Dose constraints for 1 to 8 fractions of SABR were collected for 33 OARs. Variability was found in the absolute allowable OAR doses, use of planning OAR volumes, and whether constraints were optional versus mandatory. For many OARs, modal dose constraints often matched a pre-existing publication, but no single pre-existing publication matched the modes of all OAR dose constraints. Organs displaying the most variability were the rectum, penile bulb, and chest wall and ribs. The esophagus, stomach, duodenum, and small bowel also indicated high variability for at least 1 constraint. OARs previously evaluated by HyTEC appeared to have less variability among study protocols.We found substantial variability in OAR dose constraints used in current clinical trials evaluating SABR in oligometastatic disease. We are unable to comment on toxicity rates or acceptability of dose constraints used. Future research and recommendations for standardized OAR dose constraints, as well as consistency in implementing planning OAR volume margins, should be priorities for the field of radiation oncology.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Duke完成签到,获得积分10
刚刚
半颗橙子完成签到 ,获得积分10
1秒前
wangxudk发布了新的文献求助10
1秒前
cdercder的应助被平淡傲南采纳,获得10
1秒前
quan完成签到 ,获得积分10
1秒前
cdhuang完成签到 ,获得积分10
1秒前
肆汐完成签到,获得积分10
1秒前
丘比特的应助被冷酷从阳采纳,获得10
1秒前
1秒前
1秒前
1q2w发布了新的文献求助10
1秒前
完美世界的应助被001采纳,获得10
2秒前
user_333完成签到,获得积分10
2秒前
隐形曼青的应助被qjq琪采纳,获得10
2秒前
wenxixin完成签到,获得积分10
2秒前
GingerF的应助被烟雨落长川采纳,获得50
2秒前
2秒前
duyi0521完成签到,获得积分10
3秒前
3秒前
研友_VZG7GZ的应助被大白采纳,获得10
3秒前
乄言完成签到,获得积分10
3秒前
喵小酥完成签到 ,获得积分10
4秒前
鲜衣怒马完成签到,获得积分20
4秒前
东郭南珍发布了新的文献求助10
4秒前
4秒前
4秒前
可爱的函函的应助被ZHT采纳,获得10
5秒前
冷静的千凝完成签到 ,获得积分10
5秒前
即将拥有腹肌的小王完成签到,获得积分10
5秒前
啊对对对完成签到 ,获得积分10
5秒前
yunshan发布了新的文献求助10
5秒前
5秒前
unicorn发布了新的文献求助20
5秒前
璐璐在这发布了新的文献求助10
5秒前
美好的每一天完成签到,获得积分10
5秒前
小友完成签到,获得积分10
6秒前
Xie完成签到,获得积分10
6秒前
贺雪发布了新的文献求助10
6秒前
hanyangyang发布了新的文献求助10
6秒前
有人高喊立刻脚后跟完成签到,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173962
求助须知:如何正确求助?哪些是违规求助? 9566073
关于积分的说明 21784460
捐赠科研通 7768184
什么是DOI,文献DOI怎么找? 3431663
关于科研通互助平台的介绍 2555907
邀请新用户注册赠送积分活动 2476936